SCHEMBL17835013

SCHEMBL17835013

Brc1ccccc1N(c1ccccc1)c1ccc(-c2ccccc2-c2ccccc2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.50
MAPK1 P28482 3/20 0.50
L3MBTL1 Q9Y468 3/20 0.35
MAPT P10636 2/20 0.35
KDM4E B2RXH2 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
PTGS2 P35354 1/20 0.34
TP53 P04637 1/20 0.33
NFKB1 P19838 1/20 0.33
RAB9A P51151 1/20 0.33
NFKB2 Q00653 1/20 0.33
RELA Q04206 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
NR1H2 P55055 1/20 0.33
NR1H3 Q13133 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20068420 0.91 ALDH1A1 (0.43) ALDH1A1MAPK1L3MBTL1MAPTKDM4E
SCHEMBL16186691 0.89 ALDH1A1 (0.44) ALDH1A1MAPK1L3MBTL1MAPTKDM4E
SCHEMBL15030704 0.89 ALDH1A1 (0.44) ALDH1A1MAPK1L3MBTL1MAPTKDM4E
SCHEMBL17955172 0.85 ALDH1A1 (0.48) ALDH1A1MAPK1L3MBTL1MAPTKDM4E
SCHEMBL1168198 0.84 ALDH1A1 (0.41) ALDH1A1MAPK1L3MBTL1MAPTKDM4E
SCHEMBL30282355 0.84 ALDH1A1 (0.41) ALDH1A1MAPK1L3MBTL1MAPTKDM4E
SCHEMBL15377824 0.82 ALDH1A1 (0.39) ALDH1A1MAPK1L3MBTL1MAPTKDM4E
SCHEMBL16684030 0.82 ALDH1A1 (0.55) ALDH1A1MAPK1L3MBTL1MAPTKDM4E
SCHEMBL16742271 0.81 ALDH1A1 (0.65) ALDH1A1MAPK1L3MBTL1MAPTKDM4E
SCHEMBL18916874 0.81 ALDH1A1 (0.65) ALDH1A1MAPK1L3MBTL1MAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10683453-B2 Organic compounds with soluble groups MERCK PATENT GMBH (DE) 2020-06-16 US disclosed
EP-3230403-B1 ORGANIC COMPOUNDS WITH SOLUBLE GROUPS MERCK PATENT GMBH (DE) 2019-10-09 EP disclosed
US-20170369773-A1 ORGANIC COMPOUNDS WITH SOLUBLE GROUPS UDC IRELAND LIMITED (IE) 2017-12-28 US disclosed
WO-2016091353-A1 ORGANIC COMPOUNDS WITH SOLUBLE GROUPS MERCK PATENT GMBH (DE) 2016-06-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170369773-A1 ORGANIC COMPOUNDS WITH SOLUBLE GROUPS SLCO4C1, SLCO1B3, SLCO2B1 ALDH1A1 332/4885MAPK1 3165/4885L3MBTL1 3504/4885
US-10683453-B2 Organic compounds with soluble groups SLCO4C1, SLCO1B3, SLCO2B1 ALDH1A1 332/4885MAPK1 3165/4885L3MBTL1 3504/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.